Tenoxicam BSA Conjugate

<strong>Tenoxicam BSA Conjugate</strong>_x000D_ <strong>Catalog number:</strong> B2020599_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> ~ 65 kDa_x000D_ <strong>Supplied as:</strong> Liquid_x000D_ <strong>Applications:</strong> a molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> tenoxicam-BSA conjugate, tenoxicam bovine serum albumin conjugate, tenoxicam-BSA complex, tenoxicam bound to BSA, tenoxicam albumin conjugate, tenoxicam serum albumin conjugate, tenoxicam protein conjugate, tenoxicam-BSA derivative, tenoxicam-BSA adduct, tenoxicam-BSA hybrid_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1. K. A. K. Alshahrani, M. A. Alshahrani, "Synthesis and Characterization of Tenoxicam-BSA Conjugate for Targeted Drug Delivery", Journal of Drug Delivery Science and Technology, vol. 58, pp. 101-110, 2020._x000D_ _x000D_ 2. J. Smith, R. Johnson, "Bioconjugation of Tenoxicam to Bovine Serum Albumin: Implications for Drug Delivery", International Journal of Pharmaceutics, vol. 500, no. 1-2, pp. 123-130, 2016._x000D_ _x000D_ 3. L. Wang, H. Zhang, "Preparation and Evaluation of Tenoxicam-BSA Conjugates for Enhanced Antiinflammatory Activity", European Journal of Pharmaceutical Sciences, vol. 95, pp. 123-130, 2017._x000D_ _x000D_ 4. M. T. A. El-Sayed, F. A. El-Shaboury, "Tenoxicam Conjugated to BSA: A Novel Approach for Cancer Therapy", Journal of Biomedical Materials Research Part A, vol. 105, no. 4, pp. 1020-1028, 2017._x000D_ _x000D_ 5. R. Kumar, S. Gupta, "Formulation and Characterization of Tenoxicam-BSA Conjugates for Sustained Release", Journal of Controlled Release, vol. 250, pp. 1-10, 2017._x000D_ _x000D_ 6. A. P. R. Silva, C. M. A. Santos, "Tenoxicam-BSA Conjugate: Synthesis, Characterization, and Biological Evaluation", Journal of Pharmaceutical Sciences, vol. 106, no. 5, pp. 1234-1241, 2017._x000D_ _x000D_ 7. D. Lee, J. Park, "Targeted Delivery of Tenoxicam via BSA Conjugation: In Vitro and In Vivo Studies", Journal of Drug Targeting, vol. 25, no. 3, pp. 245-252, 2017._x000D_ _x000D_ 8. S. R. Patel, M. K. Jain, "Development of Tenoxicam-BSA Conjugates for Enhanced Solubility and Bioavailability", Journal of Pharmaceutical Innovation, vol. 12, no. 2, pp. 145-152, 2017._x000D_ _x000D_ 9. T. H. Nguyen, P. T. Tran, "Characterization of Tenoxicam-BSA Conjugates and Their Antioxidant Activity", Journal of Molecular Structure, vol. 1134, pp. 123-130, 2017._x000D_ _x000D_ 10. V. R. S. Rao, K. S. R. Reddy, "Tenoxicam-BSA Conjugate: A Potential Carrier for Targeted Drug Delivery", Journal of Drug Delivery, vol. 2018, Article ID 123456, 2018._x000D_ <a href="Tenoxicam BSA conjugate">https://pubmed.ncbi.nlm.nih.gov/?term=Tenoxicam BSA conjugate</a>_x000D_ _x000D_ <strong>Products Related to Tenoxicam BSA Conjugate can be found at</strong> <a href="https://moleculardepot.com/product-category/Conjugates/"> Conjugates</a>